Day 2 of the Review of Current Practices (RCP) on venous thromboembolism (VTE) builds on foundational concepts with a sharper focus on high-risk scenarios and evolving treatment paradigms. Chaired by Lt Gen (Dr.) Velu Nair (Retd.), the day features 4 expert-led sessions designed to refine clinical decision-making.

The evening begins with a recap of key Day 1 insights, followed by a keynote by Dr. Velu Nair on cancer-associated thrombosis, addressing treatment complexities in high-risk patients. Then presents emerging evidence in anticoagulation, with insights from the COBRRA trial and its clinical implications.

Subsequent sessions include rationalizing the use of DOACs, LMWH, and oral anticoagulants, and a discussion on selecting between interventional and medical management strategies in VTE.

The program concludes with closing remarks and key takeaways, reinforcing practical application. As with Day 1, the format remains highly interactive with live polls, audience engagement, and knowledge assessments, ensuring meaningful learning outcomes for participants.

RCP VTE 2026 - Day 2

An interactive panel discussion on personalizing VTE management in challenging patient populations. Led by Dr. Velu Nair, the session tackles clinical grey zones, including obesity, active bleeding risk, stroke prevention in atrial fibrillation (SPAF), renal failure, and VTE in young adults, providing nuanced, individualized approaches grounded in current evidence and real-world practice.

From Guidelines to Ground Reality: Personalizing VTE Management in the Grey Zone Population

This session explores the interventional and surgical dimensions of catheter-related thrombosis, a clinically significant yet often underrecognized complication. The session covers pathophysiology, diagnostic approach, and evidence-informed management strategies, offering perspectives on when to intervene surgically versus medically in patients with catheter-associated deep vein thrombosis.

Implementation of National VTE Preventive Strategies

The Review of Current Practices (RCP) on venous thromboembolism (VTE) kicks off with a focused and clinically rich Day 1, chaired by Lt Gen (Dr.) Velu Nair (Retd.). Designed for busy clinicians, the evening features 3 expert-led sessions that lay the foundation for evidence-based VTE management.

The agenda begins with an overview of contemporary approaches, followed by a discussion of thromboprophylaxis and risk stratification, emphasizing translation of evidence into real-world clinical decision-making. This is complemented by a session on catheter-related thrombosis, bringing in interventional and surgical perspectives.

The day culminates in an in-depth panel discussion, focusing on personalizing VTE management in complex “grey zone” populations, including obesity, bleeding risk, renal dysfunction, and young adults.

With interactive elements such as live polls, audience Q&A, and case-based insights, Day 1 sets the stage for a practical, nuanced understanding of VTE management. Participants will also engage through pre–post assessments, with certificates awarded upon completion.

RCP VTE 2026 - Day 1

Senior Consultant Surgeon, Institute of Minimal Access, Metabolic and Bariatric Surgery, Sir Ganga Ram Hospital, New Delhi

Dr. Prof Suviraj John

4

1.8k

59.5k

4.7

Sessions Taken

533

4.8

545

4.7

547

4.7

531

4.7